Peanut therapy shows promise in treating peanut allergy
NIH-funded clinical study is one of the first to evaluate sublingual immunotherapy as a peanut allergy treatment
2013-01-07
(Press-News.org) WHAT:
A new study supported by the National Institutes of Health (NIH) suggests that sublingual immunotherapy (SLIT) can reduce the allergic response to peanut in adolescents and adults. SLIT is a treatment approach in which, under medical supervision, people place a small amount of allergen under the tongue to decrease their sensitivity to the allergen. This is one of the first randomized, placebo-controlled studies to test the efficacy and safety of SLIT to treat peanut allergy and is one of several federally funded trials investigating immune-based approaches to preventing and treating food allergy. The results appear online in the January issue of the Journal of Allergy and Clinical Immunology.
The study enrolled 40 people aged 12 to 37 years with peanut allergy who were on a peanut-free diet. After an initial food challenge to measure how much peanut powder they could eat without having an allergic reaction, participants received 44 weeks of daily therapy, followed by a second food challenge. Fourteen of the 20 participants (70 percent) given peanut SLIT were able to consume at least 10 times more peanut powder than they could at the beginning of the study, compared with only 3 of the 20 participants (15 percent) given placebo. After 68 weeks on peanut SLIT, on average, participants could consume significantly more peanut powder without having an allergic reaction. Study investigators also observed that SLIT caused only minor side effects, such as itching in the mouth, suggesting that daily therapy is safe.
Although more work is needed, the investigators hope that SLIT could one day help protect people with peanut allergy from experiencing severe allergic reactions in cases of accidental exposure. The researchers caution that people should not try peanut SLIT on their own because any form of immunotherapy carries a significant risk for allergic reactions. The therapy should be administered only under the guidance of trained clinicians.
###
The multicenter study was supported by the NIH's National Institute of Allergy and Infectious Diseases (NIAID) and conducted by the Consortium of Food Allergy Research (CoFAR) at clinical sites in Baltimore; Chapel Hill, N.C.; Denver; Little Rock, Ark.; and New York City. CoFAR investigators David Fleischer, M.D., associate professor of pediatrics in the Division of Pediatric Allergy and Immunology at National Jewish Health in Denver, and A. Wesley Burks, M.D., chair of the Department of Pediatrics at the University of North Carolina, Chapel Hill, led the trial.
ARTICLE:
DM Fleischer et al. Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. Journal of Allergy and Clinical Immunology DOI: 10.1016/j.jaci.2012.11.011 (2013).
WHO:
Marshall Plaut, M.D., chief, Food Allergy, Atopic Dermatitis, and Allergic Mechanisms Section, NIAID's Division of Allergy, Immunology, and Transplantation, is available to discuss this study.
RESOURCE INFORMATION:
This work was funded by NIAID, NIH, under grant numbers U19AI066738 and U01AI066560, and by the National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH, under grant numbers UL1RR025780, UL1TR000067, UL1TR000039, UL1RR024128, and UL1RR025005. The ClinicalTrials.gov identifier for the study A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial is NCT00580606.
CONTACT:
To schedule interviews, please contact the NIAID Office of Communications.
NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.
About the National Institutes of Health (NIH):
NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov/.
NIH...Turning Discovery Into Health END
ELSE PRESS RELEASES FROM THIS DATE:
2013-01-07
Amsterdam, NL, 7 January 2013 – Scientists have wrestled to understand why Huntington's disease, which is caused by a single gene mutation, can produce such variable symptoms. An authoritative review by a group of leading experts summarizes the progress relating cell loss in the striatum and cerebral cortex to symptom profile in Huntington's disease, suggesting a possible direction for developing targeted therapies. The article is published in the latest issue of the Journal of Huntington's Disease.
Huntington's disease (HD) is an inherited progressive neurological disorder ...
2013-01-07
CHAMPAIGN, lll. — Researchers have discovered a new compound that restores the health of mice infected with methicillin-resistant Staphylococcus aureus (MRSA), an otherwise dangerous bacterial infection. The new compound targets an enzyme not found in human cells but which is essential to bacterial survival.
The research team, led by scientists at the University of Illinois and the University of California, San Diego, reports the new findings in the Proceedings of the National Academy of Sciences. The team discovered and developed several compounds that are promising ...
2013-01-07
Gastrointestinal bleeds which occur in the hospital, although rare, are a significant source of morbidity and mortality when they occur. Currently, the prophylactic use of acid-suppressive medication in non-critically ill patients in the hospital is not widely recommended. Despite this, these medications continue to be widely utilized for this purpose.
Shoshana Herzig from the Beth Israel Deaconess Medical Center in Massachusetts, USA, and her colleagues believe that there is a group of patients whose risk of gastrointestinal bleeds is high enough to warrant the routine ...
2013-01-07
Social practices and cultural beliefs of modern life are preventing healthy brain and emotional development in children, according to an interdisciplinary body of research presented recently at a symposium at the University of Notre Dame.
"Life outcomes for American youth are worsening, especially in comparison to 50 years ago," says Darcia Narvaez, Notre Dame professor of psychology who specializes in moral development in children and how early life experiences can influence brain development.
"Ill-advised practices and beliefs have become commonplace in our culture, ...
2013-01-07
An international team of astrophysicists has shown that planetary systems with very distant binary stars are particularly susceptible to violent disruptions, more so than if the systems had two stellar companions with tighter orbits around each other.
The team, led by Northwestern University's Nathan Kaib, conducted 3,000 computer simulations to study the effects of binary stellar companions (some with tight orbits around each other and others with wide or distant orbits) on the formation and evolution of planetary systems.
The researchers found that wide binary stars ...
2013-01-07
This press release is available in Spanish.
First detected in the United States a decade ago, the brown marmorated stink bug (BMSB) is now in at least 39 states, is wreaking havoc in homes and gardens, and is a major economic threat to orchard fruits, garden vegetables and row crops. It's no wonder the U.S. Department of Agriculture (USDA) ranks this pest as its top "invasive insect of interest."
But help may be on the way: USDA scientists at the Agricultural Research Service (ARS) Invasive Insect Biocontrol and Behavior Laboratory in Beltsville, Md., are searching ...
2013-01-07
BOSTON -- Critically ill patients in hospital intensive care units (ICUs) are routinely prescribed acid-suppressive medications to reduce their risk of developing stress ulcers and gastrointestinal bleeding, both of which can result from being in a stressful environment and from being intubated. Over the years, this routine practice has often been extended to patients outside the ICU, despite a lack of evidence that this population is at significant risk of these complications.
Now a study led by investigators at Beth Israel Deaconess Medical Center (BIDMC) describes ...
2013-01-07
Understanding how thoughts of mortality influence individuals' beliefs sheds light on the commonalities among different groups' motivations and could help ease tensions between opposing viewpoints, according to University of Missouri experiments that tested the relationship between awareness of death and belief in a higher power. The study found that thoughts of death increased atheists, Christians, Muslims and agnostics conviction in their own world views. For example, contrary to the wartime aphorism that there are no atheists in foxholes, thoughts of death did not cause ...
2013-01-07
EUGENE, Ore. -- (Jan. 7, 2013) -- The ability to focus and switch tasks readily amid distractions was compromised for up to two months following brain concussions suffered by high school athletes, according to a study at the University of Oregon.
Research team members, in an interview, said the discovery suggests that some athletes may need longer recovery periods than current practices dictate to lower the risk of subsequent concussions. Conventional wisdom, said lead author David Howell, a graduate student in the UO Department of Human Physiology, has typical recovery ...
2013-01-07
In France, more than 860,000 people suffer from Alzheimer's disease and related disorders, making them the largest cause of age-related loss of intellectual function. Cognitive impairments observed in Alzheimer's disease result from the accumulation of abnormal tau proteins in nerve cells undergoing degeneration . We know that obesity, a major risk factor in the development of insulin resistance and type 2 diabetes, increases the risk of dementia during the aging process. However, the effects of obesity on 'Taupathies' (i.e. tau protein-related disorders), including Alzheimer's ...
LAST 30 PRESS RELEASES:
[Press-News.org] Peanut therapy shows promise in treating peanut allergy
NIH-funded clinical study is one of the first to evaluate sublingual immunotherapy as a peanut allergy treatment
